查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1726137

流式细胞技术市场规模、份额、趋势分析报告：按产品、技术、最终用途、地区和细分市场预测，2025 年至 2030 年

Flow Cytometry Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Consumables, Software, Accessories, Services), By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 166 Pages | 商品交期: 2-10个工作天内

价格

流式细胞技术市场的成长与趋势

根据Grand View Research, Inc.的最新报告，全球流式细胞技术市场规模预计到2030年将达到70.131亿美元，预计2025年至2030年期间的复合年增长率为8.41%。

技术进步正在引入新的和改进的分析工具，例如用于即时检验（PoC）的微流体流式细胞技术的开发。此外，癌症、免疫力缺乏和感染疾病的发病率上升也在推动该产业的发展。此外，生物製药、生命科学和生物技术研究活动的研发投入不断增加，导致对流式细胞技术仪的需求量很大。最近的趋势主要集中在用于 PoC 测试的携带式微流体流式细胞技术仪的开发。

微射流与流式细胞技术相结合，为测量生物样本的多种特性提供了有用的工具。例如，多种微流体和微型检测器的现成可用性促进了基于微晶片的细胞分析仪（如光流体细胞分析仪、成像细胞分析仪和电阻细胞分析仪）的开发。微流体流式细胞技术仪的开发具有成本低、便携、紧凑、效益高等特点。这些产品价格实惠，在亚洲和非洲的新兴经济体中均可买到，推动了 PoC 测试应用的快速成长。此外，萤光染料的改进和学术研究环境中桌上型细胞分析仪的效用普及有望推动该产业的发展。

多色流式细胞技术的发展加速了该技术在开发新药活动中的应用。例如，2020年1月，贝克曼库尔特生命科学公司在欧洲推出了13色临床流式细胞技术系统DxFLEX，CE-IVD。同样，由于细胞分析的简单性和同时评估多个参数的能力，使得此类仪器被广泛用于合约研究目的。新冠疫情也刺激了技术创新，该领域新产品的推出就是明证。例如，2021 年 7 月，Metropolis Healthcare Ltd. 推出了 CoviRisk-TBNK，这是一项简单的血液测试，用于检测住院 COVID-19 患者的风险状况。

此测试将有助于评估重症监护病房 (ICU) 入院和机械通气的必要性，从而减轻医疗资源的压力。此测试是流式细胞技术的淋巴细胞亚群检测，已核准用于体外诊断。预计此类技术创新将在不久的将来推动产业成长。此外，流式细胞技术是计数和表征免疫细胞的重要工具，也有助于识别和检验潜在的遗传缺陷。该技术也用于观察和监测患者干细胞移植后的免疫反应，使器官移植成为该产业成长的主要驱动力。根据世界卫生组织统计，全球每年进行约5万例干细胞移植手术，预计未来数字将成长，并扩大该技术的应用范围。

另一方面，发展中国家可能无法负担技术先进的流式细胞技术设备，因为该设备非常昂贵。这些仪器的价格可能超过 10 万美元，对中小型医院和临床实验室的预算造成了巨大的限制。然而，索尼等一些製造商正尝试推出配备可自动执行许多流程的软体的新型设备。这些发展不仅使该技术更易于使用，而且还将有助于在不久的将来降低平均设备成本（低于 100,000 美元）。

流式细胞技术市场报告重点

  • 到2024年，由于技术进步带来的渗透率提高，设备部门将以35.30%的最大收入份额引领市场。
  • 从技术角度来看，到 2024 年，基于细胞的细分市场将占据市场主导地位，收入份额最大，达到 76.16%。
  • 按应用划分，临床领域占据市场主导地位，2024 年的收入份额最大，为 45.34%。
  • 根据最终用途，由于流式细胞技术在细胞生物学和分子诊断中的广泛应用，学术机构部门将在 2024 年占据最大的收益占有率。

目录

第一章调查方法与范围

第二章执行摘要

第三章流式细胞技术市场变数、趋势和范围

  • 市场介绍/电网展望
  • 市场规模和成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 流式细胞技术市场分析工具
    • 波特分析
    • PESTEL分析

第四章流式细胞技术市场：产品、估计和趋势分析

  • 流式细胞技术市场：产品差异分析
  • 流式细胞技术市场：产品差异分析，百万美元，2024 年对比 2030 年
  • 装置
    • 细胞分析设备
    • 电池分选设备
  • 试剂和耗材
  • 软体
  • 配件
  • 服务

第五章流式细胞技术市场：依技术、估计和趋势分析

  • 流式细胞技术市场：技术波动分析
  • 流式细胞技术市场：技术差异分析，百万美元，2024 年 vs 2030 年
  • 基于细胞
  • 以微珠为基础

第六章流式细胞技术市场：按应用的估计和趋势分析

  • 流式细胞技术市场：应用差异分析
  • 流式细胞技术市场：应用差异分析，百万美元，2024 年对比 2030 年
  • 研究
    • 製药
    • 药物凋亡
    • 细胞分选
    • 细胞週期分析
    • 免疫学
    • 细胞活力
  • 产业
  • 临床
    • 癌症
    • 器官移植
    • 免疫力缺乏
    • 血液学
    • 自体免疫疾病

第七章流式细胞技术市场：最终用途、估计和趋势分析

  • 流式细胞技术市场：最终用途变异分析
  • 流式细胞技术市场：最终用途差异分析，百万美元，2024 年 vs. 2030 年
  • 临床检测实验室
  • 学术机构
  • 商业组织
    • 生技公司
    • 製药公司
    • CRO
  • 医院

第八章流式细胞技术市场：区域、估计和趋势分析

  • 2024 年和 2030 年流式细胞技术市场占有率（按地区划分，百万美元）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 公司热图分析
  • 公司简介
    • Danaher
    • BD
    • Sysmex Corporation
    • Apogee Flow Systems Ltd.
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific, Inc.
    • Stratedigm, Inc.
    • Miltenyi BIoTec
    • Cytek Biosciences
    • Sony Group Corporation（Sony BIoTechnology Inc.）
Product Code: GVR-1-68038-412-3

Flow Cytometry Market Growth & Trends:

The global flow cytometry market size is estimated to reach USD 7,013.1 million by 2030, registering to grow at a CAGR of 8.41% from 2025 to 2030 according to a new report by Grand View Research, Inc. Technological advancements in the technique are introducing new and improved analytical tools, which include the development of microfluidic flow cytometry for Point-of-Care (PoC) testing. Furthermore, the rising prevalence of cancer, immunodeficiency disorders, and infectious diseases is driving the industry. In addition, increasing R&D investments in biopharmaceutical, life science, and biotechnology research activities have led to high demand for flow cytometry instruments. In recent years, a key focus has been on the development of portable microfluidic flow cytometry devices for PoC testing.

Microfluidics and flow cytometry together make a useful tool to measure multiple characteristics of biological samples. For instance, the easy availability of several microfluidics and miniaturized detectors have enabled the creation of microchip-based cytometers, such as optofluidic cytometer, imaging cytometer, and impedance cytometer. The development of microfluidic flow cytometry devices, which are cost-effective, portable, and compact, is beneficial. They are affordable in developing economies, such as Asia & Africa, and are enabling rapid growth in PoC testing applications. Furthermore, improvements in fluorescent dyes and the increasing utility of benchtop cytometers for academic research settings are expected to drive the industry.

Developments in multicolor flow cytometry are accelerating the adoption of the technique in novel drug development activities. For instance, in January 2020, DxFLEX, CE-IVD, a 13-colour clinical flow cytometry system was launched by Beckman Coulter Life Sciences in Europe. Similarly, easy cellular analysis by simultaneous evaluation of several parameters allows extensive use of such devices for contract research purposes. The COVID-19 pandemic also spurred innovations in the technique, as evidenced by the launch of new products in this domain. For instance, in July 2021, Metropolis Healthcare Ltd. launched CoviRisk-TBNK, a simple blood test to detect the risk status of a COVID-19 hospitalized patient.

It helps analyze patients' need for ICU facilities or ventilation and aids in the reduction of stress on healthcare resources. The test is a flow cytometry-based lymphocyte subset assay and is IVD-approved. Such innovations are anticipated to fuel industry growth in the near future. Moreover, flow cytometry is a significant tool in listing and characterizing immune cells, and is also helpful in recognizing and validating underlying genetic defects. The technique is also used to observe and monitor the immune response of patients after stem cell transplantation, and hence, organ transplantation plays an important role in boosting industry growth. According to the WHO, around 50,000 stem cell transplantations are performed globally every year, and this number is expected to grow in the near future, broadening the scope of applications for the technique.

On the other hand, instruments are highly expensive, and hence, buyers in several developing countries may not be able to afford technologically advanced flow cytometry equipment. These instruments may cost over USD 100,000 and pose significant budgetary constraints for small- & mid-sized hospitals and clinical laboratories. However, some manufacturers, such as Sony, are trying to launch newer instruments using software to automate a number of processes. Such developments would not only improve the usability of the technique but also help bring down the average instrumentation cost-under USD 100,000-in the near future.

Flow Cytometry Market Report Highlights:

  • The instrument segment led the market with the largest revenue share of 35.30% in 2024 with owing to higher penetration driven by technological developments.
  • Based on technology, the cell-based segment led the market with the largest revenue share of 76.16% in 2024.
  • Based on application, the clinical segment led the market with the largest revenue share of 45.34% in 2024.
  • Based on end use, the academic institutes segment accounted for the largest revenue share in 2024, driven by the extensive use of flow cytometry in cell biology and molecular diagnostics.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Flow Cytometry Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Growing prevalence of chronic and infectious diseases
      • 3.3.1.2. High R&D investments in biotechnology, clinical, and life science research
      • 3.3.1.3. Technological advancements in flow cytometry instruments and reagents
      • 3.3.1.4. Increasing demand for point-of-care diagnostics
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. High cost of instruments
  • 3.4. Flow Cytometry Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Flow Cytometry Market: Product Estimates & Trend Analysis

  • 4.1. Flow Cytometry Market: Product Movement Analysis
  • 4.2. Flow Cytometry Market: Product Movement Analysis, USD Million, 2024 & 2030
  • 4.3. Instruments
    • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Cell Analyzers
      • 4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Cell Sorters
      • 4.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Reagents & Consumables
    • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Software
    • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Accessories
    • 4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Services
    • 4.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Flow Cytometry Market: Technology Estimates & Trend Analysis

  • 5.1. Flow Cytometry Market: Technology Movement Analysis
  • 5.2. Flow Cytometry Market: Technology Movement Analysis, USD Million, 2024 & 2030
  • 5.3. Cell-based
    • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Bead-based
    • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Flow Cytometry Market: Application Estimates & Trend Analysis

  • 6.1. Flow Cytometry Market: Application Movement Analysis
  • 6.2. Flow Cytometry Market: Application Movement Analysis, USD Million, 2024 & 2030
  • 6.3. Research
    • 6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Pharmaceutical
      • 6.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.3.2.2. Drug Discovery
        • 6.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.3.2.3. Drug In Vitro Toxicity
        • 6.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.3.2.4. Drug Stem Cell
        • 6.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Drug Apoptosis
      • 6.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Cell Sorting
      • 6.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Cell Cycle Analysis
      • 6.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Immunology
      • 6.3.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Cell Viability
  • 6.4. Industrial
    • 6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Clinical
    • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Cancer
      • 6.5.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Organ Transplantation
      • 6.5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. Immunodeficiency
      • 6.5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Hematology
      • 6.5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Autoimmune Disorders

Chapter 7. Flow Cytometry Market: End Use Estimates & Trend Analysis

  • 7.1. Flow Cytometry Market: End Use Movement Analysis
  • 7.2. Flow Cytometry Market: End Use Movement Analysis, USD Million, 2024 & 2030
  • 7.3. Clinical Testing Labs
    • 7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Academic Institutes
    • 7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Commercial Organizations
    • 7.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Biotechnology Companies
      • 7.5.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Pharmaceutical Companies
      • 7.5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. CROs
  • 7.6. Hospitals
    • 7.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Flow Cytometry Market: Regional Estimates & Trend Analysis

  • 8.1. Flow Cytometry Market Share, By Region, 2024 & 2030, USD Million
  • 8.2. North America
    • 8.2.1. North America Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.2.2.2. Country Dynamics
      • 8.2.2.3. Competitive Scenario
      • 8.2.2.4. Regulatory Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.2.3.2. Country Dynamics
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.2.4.2. Country Dynamics
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Scenario
  • 8.3. Europe
    • 8.3.1. Europe Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.2.2. Country Dynamics
      • 8.3.2.3. Competitive Scenario
      • 8.3.2.4. Regulatory Scenario
    • 8.3.3. Germany
      • 8.3.3.1. Germany Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.3.2. Country Dynamics
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Scenario
    • 8.3.4. France
      • 8.3.4.1. France Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.4.2. Country Dynamics
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Scenario
    • 8.3.5. Italy
      • 8.3.5.1. Italy Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.5.2. Country Dynamics
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Scenario
    • 8.3.6. Spain
      • 8.3.6.1. Spain Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.6.2. Country Dynamics
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.7.2. Country Dynamics
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.8.2. Country Dynamics
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.9.2. Country Dynamics
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.4.2.2. Country Dynamics
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Regulatory Scenario
    • 8.4.3. China
      • 8.4.3.1. China Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.4.3.2. Country Dynamics
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Scenario
    • 8.4.4. India
      • 8.4.4.1. India Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.4.4.2. Country Dynamics
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Scenario
    • 8.4.5. Australia
      • 8.4.5.1. Australia Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.4.5.2. Country Dynamics
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Scenario
    • 8.4.6. South Korea
      • 8.4.6.1. South Korea Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.4.6.2. Country Dynamics
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Scenario
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.4.7.2. Country Dynamics
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.5.2.2. Country Dynamics
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. Regulatory Scenario
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.5.3.2. Country Dynamics
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Scenario
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.6.2.2. Country Dynamics
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. Regulatory Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. South Africa Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.6.3.2. Country Dynamics
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.6.4.2. Country Dynamics
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.6.5.2. Country Dynamics
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Scenario

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Danaher
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. BD
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. Sysmex Corporation
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. Apogee Flow Systems Ltd.
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. Bio-Rad Laboratories, Inc.
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. Thermo Fisher Scientific, Inc.
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. Stratedigm, Inc.
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Miltenyi Biotec
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. Cytek Biosciences
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives
    • 9.4.10. Sony Group Corporation (Sony Biotechnology Inc.)
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Regulatory status and recommended validation strategy for flow cytometry assays
  • Table 3 CPT codes for flow cytometry reimbursement
  • Table 4 Global flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 5 Global flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 6 Global flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 7 Global flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 8 Global flow cytometry market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 11 North America flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 12 North America flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 13 North America flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 14 U.S. Flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 15 U.S. Flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 16 U.S. Flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 17 U.S. Flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 18 Canada flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 19 Canada flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 20 Canada flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 21 Canada flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 22 Mexico flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 23 Mexico flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Mexico flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 25 Mexico flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 26 Europe flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 27 Europe flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 28 Europe flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 29 Europe flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 30 Europe flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 31 Germany flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 32 Germany flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Germany flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 34 Germany flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 35 UK flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 36 UK flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 37 UK flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 38 UK flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 39 France flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 40 France flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 41 France flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 42 France flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 43 Italy flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 44 Italy flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 45 Italy flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 46 Italy flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 47 Spain flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 48 Spain flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Spain flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 50 Spain flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 51 Denmark flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 52 Denmark flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 53 Denmark flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 54 Denmark flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 55 Sweden flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 56 Sweden flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 57 Sweden flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 58 Sweden flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 59 Norway flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 60 Norway flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Norway flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 62 Norway flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 63 Asia pacific flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 64 Asia pacific flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 65 Asia pacific flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 66 Asia pacific flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 67 Asia pacific flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 68 China flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 69 China flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 70 China flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 71 China flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 72 India flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 73 India flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 74 India flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 75 India flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 76 Japan flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 77 Japan flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 78 Japan flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 79 Japan flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 80 South Korea flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 81 South Korea flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 82 South Korea flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 83 South Korea flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 84 Australia flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 85 Australia flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 86 Australia flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 87 Australia flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 88 Thailand flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 89 Thailand flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Thailand flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 91 Thailand flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 92 Latin America flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 93 Latin America flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 94 Latin America flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 95 Latin America flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 96 Latin America flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 97 Brazil flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 98 Brazil flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 99 Brazil flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 100 Brazil flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 101 Argentina flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 102 Argentina flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 103 Argentina flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 104 Argentina flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 105 Middle east & Africa flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 106 Middle east & Africa flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 107 Middle east & Africa flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 108 Middle east & Africa flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 109 Middle east & Africa flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 110 South Africa flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 111 South Africa flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 112 South Africa flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 113 South Africa flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 117 Saudi Arabia flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 118 UAE flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 119 UAE flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 120 UAE flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 121 UAE flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 122 Kuwait flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 123 Kuwait flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 124 Kuwait flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 125 Kuwait flow cytometry market, end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Volume price analysis
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook (2024)
  • Fig. 15 Flow cytometry market driver impact
  • Fig. 16 Flow cytometry market restraint impact
  • Fig. 17 Porter's five force analysis
  • Fig. 18 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 19 Flow cytometry market: product outlook & key takeaways
  • Fig. 20 Flow cytometry market: product movement analysis
  • Fig. 21 Global instruments market, 2018 - 2030 (USD Million)
  • Fig. 22 Global cell analyzers market, 2018 - 2030 (USD Million)
  • Fig. 23 Global cell sorters market, 2018 - 2030 (USD Million)
  • Fig. 24 Global reagents & consumables market, 2018 - 2030 (USD Million)
  • Fig. 25 Global software market, 2018 - 2030 (USD Million)
  • Fig. 26 Global accessories market, 2018 - 2030 (USD Million)
  • Fig. 27 Global services market, 2018 - 2030 (USD Million)
  • Fig. 28 Flow cytometry market: technology outlook & key takeaways
  • Fig. 29 Flow cytometry market: technology movement analysis
  • Fig. 30 Global cell-based market, 2018 - 2030 (USD Million)
  • Fig. 31 Global bead-based market, 2018 - 2030 (USD Million)
  • Fig. 32 Flow cytometry market: application outlook & key takeaways
  • Fig. 33 Flow cytometry market: application movement analysis
  • Fig. 34 Global research application market, 2018 - 2030 (USD Million)
  • Fig. 35 Global pharmaceutical application market, 2018 - 2030 (USD Million)
  • Fig. 36 Global drug discovery application market, 2018 - 2030 (USD Million)
  • Fig. 37 Global in vitro toxicity application market, 2018 - 2030 (USD Million)
  • Fig. 38 Global stem cell application market, 2018 - 2030 (USD Million)
  • Fig. 39 Global apoptosis application market, 2018 - 2030 (USD Million)
  • Fig. 40 Global cell sorting application market, 2018 - 2030 (USD Million)
  • Fig. 41 Global cell cycle analysis application market, 2018 - 2030 (USD Million)
  • Fig. 42 Global immunology application market, 2018 - 2030 (USD Million)
  • Fig. 43 Global cell viability application market, 2018 - 2030 (USD Million)
  • Fig. 44 Global other applications market, 2018 - 2030 (USD Million)
  • Fig. 45 Global industrial application market, 2018 - 2030 (USD Million)
  • Fig. 46 Global clinical application market, 2018 - 2030 (USD Million)
  • Fig. 47 Global cancer application market, 2018 - 2030 (USD Million)
  • Fig. 48 Global organ transplantation application market, 2018 - 2030 (USD Million)
  • Fig. 49 Global immunodeficiency application market, 2018 - 2030 (USD Million)
  • Fig. 50 Global hematology application market, 2018 - 2030 (USD Million)
  • Fig. 51 Global autoimmune disorders market, 2018 - 2030 (USD Million)
  • Fig. 52 Flow cytometry market: end use outlook & key takeaways
  • Fig. 53 Flow cytometry market: end use movement analysis
  • Fig. 54 Global commercial organizations market, 2018 - 2030 (USD Million)
  • Fig. 55 Global biotechnology companies market, 2018 - 2030 (USD Million)
  • Fig. 56 Global pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 57 Global CROs market, 2018 - 2030 (USD Million)
  • Fig. 58 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 59 Global academic institutes market, 2018 - 2030 (USD Million)
  • Fig. 60 Global clinical testing labs market, 2018 - 2030 (USD Million)
  • Fig. 61 Regional marketplace: key takeaway
  • Fig. 62 Flow cytometry market: regional movement analysis
  • Fig. 63 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Singapore market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)